Late pregnancy termination by a medical technique in combination with cervical osmotic dilators
- Authors: Tyutyunnik V.L.1, Dikke G.B.2, Kan N.E.1, Uzdenova Z.K.3, Shcherbatykh E.Y.4
-
Affiliations:
- Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- Academy of Medical Education named F.I. Inozemtsev
- Kh.M. Berbekov Kabardino-Balkar State University
- OOO "Umnaya Meditsina" (Smart Medicine)
- Issue: No 5 (2019)
- Pages: 149-154
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248519
- DOI: https://doi.org/10.18565/aig.2019.5.149-154
- ID: 248519
Cite item
Abstract
Full Text
About the authors
Victor L. Tyutyunnik
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: tioutiounnik@mail.ru
MD, professor, the head of the Obstetric Physiological Department
Galina B. Dikke
Academy of Medical Education named F.I. Inozemtsev
Email: galadikke@yandex.ru
MD, professor of the Department of Obstetrics and Gynecology with a course of reproductive medicine
Natalia E. Kan
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: kan-med@mail.ru
MD, professor, Department of Obstetrics and Gynecology
Zuhra Kh. Uzdenova
Kh.M. Berbekov Kabardino-Balkar State University
Email: elifiya@bk.ru
MD, professor of the Department of Pediatric Diseases, Obstetrics and Gynecology, honored doctor of the Kabardino-Balkarian Republic
Evgenia Yu. Shcherbatykh
OOO "Umnaya Meditsina" (Smart Medicine)
Email: skvoshechka@mail.ru
PhD, medical center «Smart Medicine», obstetrician-gynecologist.
References
- Какорин Е.П., Стародубов В.И., ред. Основные показатели здоровья матери и ребенка, деятельность службы охраны детства и родовспоможения в Российской Федерации. М.: Министерство здравоохранения Российской Федерации, Департамент мониторинга, анализа и стратегического развития здравоохранения, ФГБУ«Центральный научно-исследовательский институт организации и информатизации здравоохранения» Минздрава Российской Федерации; 2018. 171 с
- Frick A.C., Drey E.A., Diedrich J.T., Steinauer J.E. Effect of prior cesarean delivery on risk of second-trimester surgical abortion complications. Obstet. Gynecol. 2010; 115(4): 760-4.
- Fox M.C., Krajewski C.M. Cervical preparation for second-trimester surgical abortion prior to 20 weeks’ gestation. SFP: Clinical guidelines. Contraception. 2014; 89(2): 75-84.
- Bhattacharya S., Lowit A., Bhattacharya S., Raja E.A., Lee A.J., Mahmood T., Templeton A. Reproductive outcomes following induced abortion: a national register-based cohort study in Scotland. BMJ Open. 2012; 2(4). pii: e000911.
- Allen R.H., Goldberg A.B. Cervical dilation before first-trimester surgical abortion (<14 weeks’ gestation). Contraception. 2016; 93(4): 277-91.
- World Health Organization, Department of Reproductive Health and Research. Safe abortion: technical and policy guidance for health systems 2nd ed. WHO; 2012. Available at: http://www.who.int/
- Wildschut H., Both M.I., Medema S., Thomee E., Wildhagen M.F., Kapp N. Medical methods for mid-trimester termination of pregnancy. Cochrane Database Syst. Rev. 2011; 19(1): CD005216.
- Ngoc N.T., Shochet T., Raghavan S., Blum J., Nga N.T., Minh N.T. et al. Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial. Obstet. Gynecol. 2011; 118(3): 601-8.
- Ashok P.W., Templeton A., Wagaarachchi P.T., Flett G.M. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception. 2004; 69(1): 51-8.
- Milani F., Sharami S.H., Arjmandi S. Comparison of sublingual and vaginal misoprostol for second-trimester pregnancy terminations. J. Fam. Reprod. Health. 2014; 8(1): 41-4.
- Dickinson J.E., Jennings B.G., Doherty D.A. Mifepristone and oral, vaginal, or sublingual misoprostol for second-trimester abortion: a randomized controlled trial. Obstet. Gynecol. 2014; 123(6): 1162-8.
- Royal College of Obstetricians and Gynaecologists (RCOG). The care of women requesting induced abortion (Evidence-based Clinical Guideline No. 7). London: RCOG Press; 2011. Available at: http://www.rcog.org.uk
- Package Labeling: Dilapan-S™ Hygroscopic Cervical Dilator (International Label). Gel-Med International. Available at: http://www.dilapan.com/
- Carbonell J.L., Gallego F.G., Llorente M.P., Bermudez S.B., Sala E.S., Gonzfllez L.V., Texido C.S. Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial. Contraception. 2007; 75(3): 230-7.
- Drezett J., Bessa M.M. , Pedroso D. , Silva A.C.F. et al. Misoprostol no aborto de segundo trimestre em gestações decorrentes de violência sexual: análise de efetividade de um protocolo aplicado em serviço público de saúde brasileiro. Reprod. Climat. 2014; 29(3): 105-11
- American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 135: Second-trimester abortion. Obstet. Gynecol. 2013; 121(6): 1394-406.
- Maurer K., Jacobson J., Turok D. Same day cervical preparation with misoprostol prior to second trimester D&E: A case series. Contraception. 2013; 88(1): 116-21.
- Goldberg A.B., Drey E.A., Whitaker A.K., Kang M.S., Mecksroth K.R., Darney P.D. Misoprostol compared with laminaria before early second-trimester surgical abortion: a randomized trial. Obstet. Gynecol. 2005; 106(2): 223-41.
- Hammond C., Chasen S. Dilation and evacuation. In: Paul M., Lichtenberg E.S., Borgatta L., Grimes D.A., Stubblefield P.G., Creinin M.D., eds. Management of unintended and abnormal pregnancies: comprehensive abortion care. Oxford: Wiley-Balckwell; 2009: 157-77.
- Borgatta L., Roncari D., Sonalkar S., Mark A., Hou M.Y., Finneseth M., Vragovic O. Mifepristone vs. osmotic dilator insertion for cervical preparation prior to surgical abortion at 14-16 weeks: a randomized trial. Contraception. 2012; 86(5): 567-71.
- Patsner B. Same-day Dilapan insertion before second-trimester dilation and evacuation for a fetal anomaly or death. J. Reprod. Med. 1996; 41: 71-2.
- Lyus R., Lohr P.A., Taylor J., Morroni C. Outcomes with same-day cervical preparation with Dilapan-S osmotic dilators and vaginal misoprostol before dilatation and evacuation at 18 to 21+6 weeks’ gestation. Contraception. 2013; 87(1): 71-5.
- Chambers D.G., Willcourt R.J., Laver A.R., Baird J.K., Herbert W.Y. Comparison of Dilapan-S and laminaria for cervical priming before surgical pregnancy termination at 17-22 weeks’ gestation. Int. J. Womens Health. 2011; 3: 347-52.
- Kai K., Karakida S., Kono M., Sasaki T., Togo K., Tsuno A. et al. Effects of parity and gestational age on second-trimester induction-abortion interval in combination with osmotic dilators and gemeprost. Contraception. 2012; 86(2): 147-52.
- DC Dutta's Textbook of Obstetrics. 7th ed. London: Replica Press; 2013. 692р.
- Gupta J., Lohr P., Hanacek J., Roizin J., Taylor J. Synthetic osmotic dilator prior to medical or surgical abortion: interim outcomes from international observational E-registry. Eur. J. Obstet. Gynecol. Reprod. Biol. 2016; 206: е41.
- Кан Н.Е., Тютюнник В.Л. Завершение беременности во втором триместре. Клинический опыт. Доклад на XVIII Всероссийском научнообразовательном форуме «Мать и Дитя» 26.09.2017. (Прекурс «Современные технологии завершения беременности».) Программа XVIII Всероссийского научно-образовательного форума «Мать и Дитя» 26-29 сентября 2017 г. М.; 2017.
- Кан Н.Е., Тютюнник В.Л., Михайлова О.И. Алгоритм медикаментозного прерывания беременности во II триместре. Medica mente. Лечим с умом. 2017; 3(2): 24-5.
- Баринов С.В., Тирская Ю.И., Шамина И.В., Медянникова И.В., Шкабарня Л.Л. Применение осмотического расширителя при несостоявшемся выкидыше у женщин с тяжелой сопутствующей патологией для прерывания беременности. Акушерство и гинекология. 2017; 3: 160-4.
- Узденова З.Х. Использование дилапана при медицинском аборте у юных женщин. В. кн.: Материалы IV Всероссийской конференции по детской и подростковой гинекологии «Современные профилактические, диагностические и терапевтические технологии в клинике детской гинекологии». М.; 2000: 171-2.
- Eke A.C., Okigbo C. Mechanical methods for induction of labour: RHL commentary (last revised: 1 August 2012). Geneva: World Health Organization; 2012. Available at: https://extranet.who.int/
- Wilson L.C., Meyn L.A., Creinin M.D. Cervical preparation for surgical abortion between 12 and 18 weeks of gestation using vaginal misoprostol and Dilapan-S™. Contraception. 2011; 83(6): 511-6.
- Lichtenberg E.S. Complications of osmotic dilators. Obstet. Gynecol. Surv. 2004; 59(7): 528-36.
- Chanda M., Mackenzie P., Day J.H. Hypersensitivity reactions following laminaria placement. Contraception. 2000; 62(2): 105-6.
- Kim S.H., Chang Y.H., Kim W.K., Kim Y.K., Cho S.H., Kim Y.Y., Min K.U. Two cases of anaphylaxis after laminaria insertion. J. Korean Med. Sci. 2003; 18(6): 886-88.
- Sutkin G., Capelle S.D., Schlievert P.M., Creinin M.D. Toxic shock syndrome after laminaria insertion. Obstet. Gynecol. 2001; 98(5, Pt2): 959-61.
- Peterson W.F., Berry F.N., Grace M.R., Gulbranson C.L. Second-trimester abortion by dilatation and evacuation: an analysis of 11,747 cases. Obstet. Gynecol. 1983; 62: 185-90.
- Halperin R., Vaknin Z., Langer R., Bukovsky I., Schneider D. Late midtrimester pregnancy termination in the presence of placenta previa. J. Reprod. Med. 2003; 48(3): 175-8.